Susac syndrome with transient inverted vision.
Zeidman
L A
LA
Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.
Melen
O
O
Gottardi-Littell
N
N
Getch
C
C
Alberts
M J
MJ
Goldstein
L
L
Bernstein
R A
RA
D000328:Adult; D001327:Autoimmune Diseases / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D002544:Cerebral Infarction / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D004401:Dysarthria / Q000209:etiology; D005242:Fecal Incontinence / Q000209:etiology; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000209:etiology; D006801:Humans; D007088:Illusions / Q000209:etiology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008833:Microcirculation; D009759:Nystagmus, Pathologic / Q000209:etiology; D010259:Paranoid Disorders / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011782:Quadriplegia / Q000209:etiology; D015356:Retinal Artery Occlusion / Q000209:etiology*; D013577:Syndrome; D014549:Urinary Incontinence / Q000209:etiology; D014717:Vertigo / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology*
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone